TY - JOUR
T1 - Studies on the chemistry of thienoannelated O,N- and S,N-containing heterocycles. Part 19([1]): Thieno[2,3-b][1,4]thiazines with calcium antagonistic and potassium opening activities
AU - Erker, Thomas
AU - Galanski, Maria
AU - Studenik, Christian
N1 - DOI: 10.1002/(SICI)1521-4184(200002)333:2/3<58::AID-ARDP58>3.0.CO;2-L
Coden: ARPMA
Affiliations: Inst. of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria; Inst. of Pharmacology and Toxicology, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria
Source-File: MedPharmChemScopus_iso.csv
Import aus Scopus: 2-s2.0-0034117203
Importdatum: 22.11.2006 17:14:51
09.08.2007: Datenanforderung 1812 (Import Sachbearbeiter)
09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)
PY - 2000
Y1 - 2000
N2 - In this study novel substituted 6-benzyl-thieno[2,3-b][1,4]thiazines with an urea moiety were synthesized. Structural modifications of the amino side chain were carried out with the aim of finding tissue specific compounds. The effects on papillary muscles, right atria, aortic strips, and terminal ilea were investigated. Compounds 10c and 10d showed the most potent negative inotropic effect. The calcium antagonism of all derivatives occurred in a non-competitive manner, which may indicate that they also have potassium channel opening activities.
AB - In this study novel substituted 6-benzyl-thieno[2,3-b][1,4]thiazines with an urea moiety were synthesized. Structural modifications of the amino side chain were carried out with the aim of finding tissue specific compounds. The effects on papillary muscles, right atria, aortic strips, and terminal ilea were investigated. Compounds 10c and 10d showed the most potent negative inotropic effect. The calcium antagonism of all derivatives occurred in a non-competitive manner, which may indicate that they also have potassium channel opening activities.
U2 - 10.1002/(SICI)1521-4184(200002)333:2/3<58::AID-ARDP58>3.0.CO;2-L
DO - 10.1002/(SICI)1521-4184(200002)333:2/3<58::AID-ARDP58>3.0.CO;2-L
M3 - Article
VL - 333
SP - 58
EP - 62
JO - Archiv der Pharmazie
JF - Archiv der Pharmazie
SN - 0365-6233
IS - 2-3
ER -